BiotechTube
Home/Neurimmune/Roger M. Nitsch, MD
RM

Roger M. Nitsch, MD

CEO & President, Co-Founder

Neurimmune

Therapeutic Areas

Alzheimer's DiseaseAmyotrophic Lateral SclerosisATTR CardiomyopathySpinal Cord InjurySystemic Amyloidosis

Neurimmune Pipeline

DrugIndicationPhase
Cliramitug (ALXN2220/NI006)ATTR Cardiomyopathy (ATTR-CM)Phase 3
AP-101Amyotrophic Lateral Sclerosis (ALS)Phase 1/2
NG004Spinal Cord InjuryPhase 1
NI101B3Alzheimer's DiseasePreclinical
NI009Systemic AmyloidosisPreclinical

Leadership Team at Neurimmune

CH
Christoph Hock, MD
CMO & Director, Co-Founder
View full Neurimmune profile